Company / Cost of Revenue
Zivo Bioscience, Inc. Cost of Revenue History
FY2013-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$108.3K
FY2024
5-year range
$0 / $108.3K
FY2020-FY2024
Trend
+575.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $0 to $108,268 over the past 2 years.
Based on SEC 10-K filings.
$108,268 in FY2024.
Increased from $0 to $108,268 over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, cost of revenue increased 575.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -96.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $108.3K | +575.0% |
| FY2023 | $16.0K | - |
| FY2022 | $0 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
| FY2013 | $0 | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026